Table II.
Univariate and multivariate analysis of prognostic factors for OS and DFS in Dukes' stage B patients.
Univariate analysis | Multivariate analysis | |||||
---|---|---|---|---|---|---|
|
|
|||||
Variables | Regression coefficient | Hazard ratio (95% CI) | P-value | Regression coefficient | Hazard ratio (95% CI) | P-value |
OS | ||||||
Tumor size | 0.349 | 1.417 (0.521–3.858) | 0.488 | (−) | ||
Lymphatic invasion | 0.674 | 1.962 (0.665–5.303) | 0.209 | (−) | ||
Venous invasion | 1.109 | 3.030 (1.054–10.846) | 0.039a | 1.017 | 2.765 (0.961–9.905) | 0.060 |
Histological type | −0.235 | 0.791 (0.181–2.455) | 0.708 | (−) | ||
Serum CEA | 0.744 | 2.105 (0.768–5.777) | 0.145 | (−) | ||
Serum CA19-9 | 0.588 | 1.800 (0.394–6.235) | 0.409 | (−) | ||
CEA/CK/CD133 | 2.347 | 10.456 (2.119–189.993) | 0.001a | 2.284 | 9.819 (1.987–177.568) | 0.002a |
DFS | ||||||
Tumor size | 0.053 | 1.055 (0.479–2.286) | 0.892 | (−) | ||
Lymphatic invasion | 0.570 | 1.768 (0.775–3.844) | 0.169 | (−) | ||
Venous invasion | 0.840 | 2.316 (1.040–5.645) | 0.040a | 0.619 | 1.857 (0.824–4.569) | 0.139 |
Histological type | 0.376 | 1.456 (0.597–3.242) | 0.389 | (−) | ||
Serum CEA | 0.798 | 2.222 (0.823–4.901) | 0.064 | (−) | ||
Serum CA19-9 | 0.240 | 1.271 (0.360–3.546) | 0.680 | (−) | ||
CEA/CK/CD133 | 1.150 | 3.158 (1.286–9.462) | 0.011a | 1.282 | 3.602 (1.454–10.863) | 0.005a |
P<0.05.